Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Kwells Kids 150 microgram tablets
⚠ This medicine appears to have been discontinued
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Hyoscine hydrobromide may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
How to take it
KWELLS KIDS TABLETS
If Kwells Kids tablets has been prescribed for your child by a doctor, follow any instructions he/she may have given you. If you purchased this product without a prescription, follow these directions closely: The tablets can be sucked, chewed or swallowed. They have a scoreline so they can be halved if necessary. The tablets can be taken up to 30 minutes before travelling to prevent travel sickness, or even at the onset of nausea. Children over 10 years: Give your child one or two tablets every 6 hours, as required. Do not give your child this medicine more than 3 times in 24 hours. Children 4 to 10 years: Give your child half or one tablet every 6 hours, as required. Do not give your child this medicine more than 3 times in 24 hours. Kwells Kids tablets should not be given to children under 4 years of age. If your child takes more Kwells Kids tablets than recommended: Symptoms of an overdose may include: fast or irregular heart-beat, difficulty passing water, blurred vision or dislike of bright light. Hallucinations may occur. If your child has any of these symptoms or has taken more than the recommended dose, tell your doctor or contact your nearest Accident and Emergency Department immediately. How to help avoid travel sickness: ✓ Sit with the head tilted back to stabilise the balancing mechanism in the ear. ✓ Ensure the vehicle you are in is well ventilated. ✓ Try to have a clear view of the window. ✓ Have a bite to eat before the journey to help keep the stomach settled, but avoid greasy food. ✓ If you travel by car take regular breaks for exercise, fresh air and refreshments. ✓ In an aeroplane you can ease the pressure on your ears by sucking a boiled sweet during take off and landing. ✗ NEVER read. ✗ Avoid strong smelling food, smoke, perfume, or petrol fumes.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Kwells Kids tablets can cause
Possible side effects
, although not everybody gets them. Some people have experienced blurred vision, dilated pupils, dry mouth, drowsiness and dizziness. Your child may also experience an increased body temperature due to decreased sweating. Less frequently, there have been reports of restlessness, hallucinations and confusion. If your child is epileptic, he or she might suffer from increased seizure frequency.
As with all medicines, some people may be allergic to the tablets. If your child is allergic, he or she may experience difficulty in breathing, coughing, wheezing or symptoms such as rash, itching and swelling. If your child experiences any of these effects or reacts badly to the tablets in any other way, tell your doctor immediately. Reporting of side effects If you or your child get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
How to store it
KWELLS KIDS TABLETS
Keep out of the sight and reach of children. Do not store above 25 ̊C. This product should be stored in the original carton. Do not use the tablets after the expiry date which is stated on the carton and blister pack. The expiry date refers to the last day of that month. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6. FURTHER INFORMATION
What Kwells Kids tablets contain:
- The active substance is hyoscine hydrobromide at a strength of 150 micrograms.
- The other ingredients are mannitol (E421), potato starch, gelatine powder, aluminium stearate, and saccharin sodium (E954). What Kwells Kids tablets look like and contents of the pack: Kwells Kids tablets are small, circular, white and flat with a single scoreline on the surface. The carton contains 12 tablets packaged inside a blister pack. Marketing Authorisation Holder and Manufacturer: Dexcel® – Pharma Ltd., 2nd Floor, Bourn 1 Manor House Drive, Coventry CV1 2FX, UK This leaflet was last revised in November 2025. Remember: If you have any doubts about using Kwells Kids correctly, seek the advice of your doctor or pharmacist.
Frequently asked questions about Kwells Kids 150 microgram tablets
How do I take Kwells Kids 150 microgram tablets?
Kwells Kids 150 microgram tablets comes as tablet containing 150mcg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
What is the active substance in Kwells Kids 150 microgram tablets?
The active substance in Kwells Kids 150 microgram tablets is hyoscine hydrobromide.
Where does this information come from?
This leaflet reproduces the patient information leaflet approved for Kwells Kids 150 microgram tablets, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Can I get Kwells Kids 150 microgram tablets without a prescription?
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
About this leaflet
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
- Source: electronic medicines compendium (emc), Datapharm
- Active substance: hyoscine hydrobromide
- Official document: view the original leaflet on emc →
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
4.1. Therapeutic indications
For the prevention of travel sickness.
4.2. Posology and method of administration
Tablets to be sucked, chewed or swallowed.
Tablets to be taken up to 30 minutes before the start of the journey to prevent travel sickness, or at the onset of nausea.
Adults:
Not applicable.
Elderly persons:
Not applicable.
Children:
Children over 10: 1-2 tablets every 6 hours if required. Do not take more than 3-6 tablets in 24 hours.
Children 4-10: ½-1 tablet every 6 hours if required. Do not take more than 1½-3 tablets in 24 hours.
4.3. Contraindications
Prostatic enlargement, paralytic ileus, pyloric stenosis, glaucoma and myasthenia gravis.
In addition, Kwells should not be given to patients with a known sensitivity to hyoscine hydrobromide or any other component of the product.
4.4. Special warnings and precautions for use
The elderly and patients under medical care (in particular those at risk of acute urinary retention, or with cardiovascular, metabolic, gastrointestinal, liver or renal disease, or suffering from CNS disorders such as seizures) should consult a doctor before taking this product.
In patients with ulcerative colitis its use may lead to ileus or megacolon.
Antimuscarinics should be used with caution in persons with Down's Syndrome. Caution is advisable in patients with diarrhoea.
Hyperthermia can occur at high ambient temperatures due to decreased sweating, therefore, Kwells should be used with caution in patients with fever.
4.5. Interaction with other medicinal products and other forms of interaction
The effects of hyoscine may be enhanced by other drugs with anticholinergic properties (including amantadine, some antihistamines, phenothiazine antipsychotics and tricyclic antidepressants), therefore, combining these drugs with hyoscine should be avoided.
There may be an increased risk of side effects when given with MAOIs due to inhibition of drug-metabolising enzymes.
The sedative effect of Kwells may be enhanced with alcohol or CNS depressants.
The reduction in gastric motility caused by Kwells may also affect the absorption of other drugs. There is an antagonism of effect of domperidone and metoclopramide on gastro-intestinal activity.
There could be a reduced effect of sublingual nitrate tablets due to the failure to dissolve properly under the tongue owing to dry mouth.
4.6. Fertility, pregnancy and lactation
The safety of this medicine in pregnancy has not been established. It should only be used during pregnancy, particularly in the first trimester, if the expected benefit to the mother outweighs any potential risk to the developing foetus.
Caution is required during lactation as small amounts of this medicine may pass into breast milk.
4.7. Effects on ability to drive and use machines
May cause drowsiness. If affected do not drive or operate machinery.
4.8. Undesirable effects
The listed adverse drug reactions are based on spontaneous reports, thus an organization according to CIOMS II categories of frequency is not pertinent.
General: hyperthermia at high temperatures due to decreased sweating.
Eye disorders: blurred vision, mydriasis.
Gastrointestinal disorders: dry mouth.
Immune system disorders: allergic reaction and anaphylactic reaction. Hypersensitivity reactions with respective laboratory and clinical manifestations, including asthma syndrome, mild to moderate reactions affecting skin, respiratory tract, gastrointestinal tract, and cardiovascular system, and symptoms such as rash, urticaria, oedema, pruritus, cardio-respiratory distress, have been reported.
Nervous system disorders: drowsiness, dizziness, sedation and sonmolence are commonly reported. Central nervous system stimulation including restlessness, hallucinations and confusion, have been less frequently reported following the administration of hyoscine.
There have been rare reports of an increase in seizure frequency in epileptic patients (the same caution for this patient population is included in Section 4.4).
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk!yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
4.9. Overdose
The symptoms of overdosage are tachycardia, arrhythmia, blurring of vision and photophobia, urinary retention. Drowsiness is usual, but paradoxical stimulation with hallucinations may occur.
Treatment: gastric lavage or induced emesis and symptomatic treatment.
🇵🇱 Known in Poland as
Medicines sold in Poland with the same active substance: W Polsce znany jako
⚠ Not the same combination. This medicine contains Hyoscine hydrobromide. The products below do not contain exactly the same set of active substances — they are not direct substitutes.
- Buscopan partial — not the same combinationHyoscini butylbromidum · taken by mouth
- Buscopan forte partial — not the same combinationHyoscini butylbromidum · taken by mouth
- AuroGastro partial — not the same combinationHyoscini butylbromidum · taken by mouth
- Panadol Femina partial — not the same combinationParacetamolum + Hyoscini butylbromidum · taken by mouth
- Scopolan compositum partial — not the same combinationHyoscini butylbromidum + Metamizolum natricum monohydricum · taken by mouth
Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
💬 Ask about this leaflet
Ask anything about Kwells Kids 150 microgram tablets. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.